Nonsteroidal anti-inflammatory drugs (NSAIDs) and cyclooxygenase (COX)-2-specific inhibitors provide significant analgesic and opioid-sparing benefits. However, these analgesics are commonly avoided owing to concerns of potential adverse effects. The evidence for NSAID-related adverse effects is conflicting and of poor quality, and these analgesics are safer than what has been implied. Thus, it is imperative that NSAIDs or COX-2-specific inhibitors are administered routinely unless there are well-founded contraindications.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bja.2024.10.018 | DOI Listing |
Publication Analysis
Top Keywords
nonsteroidal anti-inflammatory
8
anti-inflammatory drugs
8
cox-2-specific inhibitors
8
adverse effects
8
drugs perioperative
4
perioperative period
4
period current
4
current controversies
4
controversies concerns
4
concerns nonsteroidal
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!